A subset of patients with metastatic pancreatic cancer and an inherited BRCA mutation rapidly progressed during a clinical trial of Lynparza.
Teresa Macarulla, M.D.
Advertisement
Articles by Teresa Macarulla, M.D.
Advertisement
Latest Updated Articles
Updates From a PARP Inhibitor Clinical Trial for Patients with Metastatic Pancreatic CancerPublished: February 1st 2020 | Updated:
Advertisement
Advertisement
Trending on CURE
1
Body Image and Sexual Health Challenges After Breast Cancer
2
What Are Non-Muscle Invasive Bladder Cancer and its Treatment Options?
3
FDA Grants Fast Track Designation to ADCE-D01 for Soft Tissue Sarcoma
4
Minimally Invasive Kidney Cancer Treatments Boosts Patient Recovery
5
